期刊文献+

米索前列醇联合利多卡因应用于瘢痕子宫人工流产的效果观察 被引量:10

米索前列醇联合利多卡因应用于瘢痕子宫人工流产的效果观察
下载PDF
导出
摘要 目的:探讨米索前列醇联合利多卡因应用于瘢痕子宫人工流产的临床效果。方法:将自愿要求行人工流产的瘢痕子宫患者共212例随机分为3组,分别为米索前列醇+利多卡因组、利多卡因组及对照组,观察各组的镇痛效果、宫口松弛度、人工流产综合征的发生率及术中出血量。结果:3组在镇痛效果、宫口松弛度、人工流产综合征的发生率上均差异存在显著性(P<0.05),A组效果好于后两组。3组术中出血量无明显差异(P>0.05)。结论:米索前列醇联合利多卡因用于瘢痕子宫人工流产收到满意的效果,宫颈软化、扩张好,不仅便于手术操作,并且减少了疼痛及RAAS的发生,提高了手术安全性。 Objective:To observe the clinical effect of Misoprostol combined with Lidocaine for artificial abortion in scarred uterus.Methods:212 early pregnant women with scarred uterus presenting for artifical abortion were randomly allocated into three group,Misoprostol combined with Lidocaine group,Lidocaine group and control group.Compare the analgesia effect,dilation of cervix,the rate of abortion syndrome and bleeding.Results:There were significant difference in the analgesia effect,dilation of cervix and the rate of abortion syndrome of the three group(P〈0.05).The effect of A group is better than others.No difference in bleeding of the three group(P〉0.05).Conclusion:Misoprostol combined with Lidocaine for artificial abortion in scarred uterus can soften the uterine neck,ease pain and reduce the rate of abortion syndrome.This method make the operation simple and improve the safety of the operation.
作者 朱学梅
出处 《中国社区医师(医学专业)》 2012年第4期124-125,共2页
关键词 米索前列醇 利多卡因 瘢痕子宫 人工流产 Misoprostol Lidocaine Scarred uterus Artificial abortion
  • 相关文献

参考文献3

二级参考文献15

  • 1[1]Preutthipan S, Herabutya Y. Vaginal misoprostol for cervical priming before operative hysteroscopy: a randomized controlled trial. Obstet Gynecol,2000,96(6):890
  • 2[2]Molin A. Risk of damage to the cervix in dilatation for first trimester induced abortion by suction aspiration. Gynecol Obstet Invest,1993,35:152
  • 3[3]Ngai SW,Chan YM, Ho PC.The use of misoprostol prior to hysteroscopy in postmenopausal women. Hum Reprod,2001,16(7):1486
  • 4[1]Ho PC, Liang ST, Tang GWK, et al. Pro-operative cervical dilatation in termination of first trimester pregnancies using 16,16-methy-trans-GPE1 methy1 ester vaginal pessaries. Contraception, 1983,27:339-346.
  • 5[2]Singh K, Fong YF. Preparation of the cervix for surgical termination of pregnancy in the first trimester. Hum Reprod Update, 2000, 6: 442-448.
  • 6[3]Ding JQ, Granberg S, Norstrom A. Clinial effects and cervical tissue changes after treatment with 16, 16 dimethyel - trans 2GPE1, menthy-lester in the first trimester. Prostaglandins, 1990,39: 281-285.
  • 7[4]Ngai SW, Chan YM, Tang OS, et al. The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomized trial. Hum Reprod, 1999, 14:2139-2142.
  • 8[5]MacIsaac L, Grossman D, Balistreri E, et al. A randomized controlled trial of laminaria, oral misoprostol, and vaginal misoprostol before abortion. Obstet Gynecol, 1999, 93: 766-770.
  • 9[7]Ashok PW, Hamoda H, Nathani F, et al. Randomised controlled study comparing oral and vaginal misoprostol for cervical priming prior to surgical termination of pregnancy. BJOG,2003, 110: 1057-1061.
  • 10[8]Carbonell JL, Velazco A, Rodriguez Y, et al. Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial. Eur J Contracept Reprod Health Care,2001, 6:134-140.

共引文献106

同被引文献43

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部